Instrument firm Elektron Technology plans to launch a consumer campaign highlighting the benefits of screening and preventative care for age-related macular degeneration (AMD) next year.
The campaign will coincide with the release of the Age-Related Eye Disease Study 2 (AREDS2) and rollout of Elektron's macular pigment screener (MPS II).
Elektron said AREDS2 was expected to report that nutritional supplements containing Omega-3 and lutein and zeaxanthin enhanced the eye's protective shield and thus protect against AMD.
The MPS II has been developed using clinical data collected from 1.5 million patients over the space of five years.
Jaquie Finn, product line manager at Elektron, said: 'Traditionally, macular pigment screening uses heterochromatic flicker photometry (HFP) to compare the thickness of the pigment in the macula with a peripheral measurement where there is no pigment. This latter test can be difficult for the patient to perform and can result in unreliable data.
Register now to continue reading
Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.
Register
Already have an account? Sign in here